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A B S T R A C T
Background
Impaction of a so# food bolus in the oesophagus causes dysphagia and regurgitation. If the bolus does not pass spontaneously, then the
patient is at risk of aspiration, dehydration, perforation, and death. Definitive management is with endoscopic intervention, recommended
within 24 hours. Prior to endoscopy, many patients undergo a period of observation, awaiting spontaneous disimpaction, or may undergo
enteral or parenteral treatments to attempt to dislodge the bolus. There is little consensus as to which of these conservative strategies is
safe and eHective to be used in this initial period, before resorting to definitive endoscopic management for persistent impaction.
Objectives
To evaluate the eHicacy of non-endoscopic conservative treatments in the management of so# food boluses impacted within the
oesophagus.
Search methods
We searched the following databases, using relevant search terms: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE,
Embase and CINAHL. The date of the search was 18 August 2019. We screened the reference lists of relevant studies and reviews on the
topic to identify any additional studies.
Selection criteria
We included randomised controlled trials of the management of acute oesophageal so# food bolus impaction, in adults and children,
reporting the incidence of disimpaction (confirmed radiologically or clinically by return to oral diet) without the need for endoscopic
intervention. We did not include studies focusing on sharp or solid object impaction.
Data collection and analysis
We used standard methodological procedures recommended by Cochrane.
Main results
We identified 890 unique records through the electronic searches. We excluded 809 clearly irrelevant records and retrieved 81 records for
further assessment. We subsequently included one randomised controlled trial that met the eligibility criteria, which was conducted in four
Swedish centres and randomised 43 participants to receive either intravenous diazepam followed by glucagon, or intravenous placebos.
The eHect of the active substances compared with placebo on rates of disimpaction without intervention is uncertain, as the numbers from
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this single study were small, and the rates were similar (38% versus 32%; risk ratio 1.19, 95% confidence interval 0.51 to 2.75, P = 0.69). The
certainty of the evidence using GRADE for this outcome is low. Data on adverse events were lacking.
Authors' conclusions
There is currently inadequate data to recommend the use of any enteral or parenteral treatments in the management of acute oesophageal
so# food bolus impaction. There is also inadequate data regarding potential adverse events from the use of these treatments, or from
potential delays in definitive endoscopic management. Caution should be exercised when using any conservative management strategies
in these patients.
P L A I N   L A N G U A G E   S U M M A R Y
Use of treatments to dislodge so foods stuck between the throat and the stomach to try to avoid the need for an endoscopy
Review question
Can a period of observation, treatment with swallowed substances, or treatment with substances given via the blood help to dislodge so#
foods that are stuck between the throat and the stomach in order to avoid the need for an endoscopic procedure to clear it?
Background
Food can sometimes get stuck in the oesophagus, the pipe connecting the throat to the stomach that passes through the chest. This food
o#en dislodges on its own, without any medical help, but occasionally a doctor's help is needed to clear it. Removing or dislodging these
lumps of food can be done using a flexible camera or a rigid instrument, called an endoscope, but endoscopic procedures can have serious
complications, like causing holes in the oesophagus. However, waiting for too long for the food to clear on its own can also increase the
risk of a hole in the oesophagus and may lead to saliva or food falling into the lungs, causing serious infections. A variety of treatments
are currently used to try to clear the food, without having to resort to an endoscopy, many of which also have potential side eHects,
including diHiculty breathing, increased blood sugar levels, low blood pressure, and irregular heartbeat. We wanted to know if any of these
treatments were better than simply waiting for the food to clear on its own, before trying to dislodge it with instruments.
Study characteristics
The evidence is current to August 2019. We found one trial suitable to answer our question, which compared giving a patient two drugs
into a vein in (diazepam and glucagon) to placebos (clear liquids which appeared similar to the drugs but have no eHect on the body). We
did not look at treating sharp or hard objects, as these are treated diHerently.
Key results
There was not enough evidence to say with certainty which treatments for food impacted in the oesophagus are safe or eHective.
Quality of the evidence
We graded the overall certainty of the evidence as low. More studies with more participants are needed to be able to answer the review
question.
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Summary of findings 1.   Diazepam and glucagon compared to placebo for the management of impacted food bolus in the oesophagus
Diazepam and glucagon compared to placebo for the management of impacted food bolus in the oesophagus
Patient or population: management of impacted food bolus in the oesophagus
Setting: 4 Swedish ear, nose, and throat (ENT) departments
Intervention: diazepam and glucagon
Comparison: placebo
Anticipated absolute effects* (95% CI)Out-
comes
Risk with placebo Risk with diazepam and glucagon
Relative effect
(95% CI)
№ of partici-
pants
(studies)
Certainty of the
evidence
(GRADE)
Comments
Study populationDisim-
paction
32 per 100 38 per 100
(16 to 87)
RR 1.19
(0.51 to 2.75)
43
(1 RCT)
⊕⊕⊝⊝
LOW 1
No significant effect from com-
bined diazepam and glucagon
compared to placebo
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.
1We assessed imprecision as very serious as the single identified study had a wide 95% confidence interval spanning 1.0.
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B A C K G R O U N D
See glossary of terms in Appendix 1.
Description of the condition
The oesophagus is a muscular tube that acts as a conduit between
the throat and stomach. It begins at the end of the pharynx, travels
through the neck and thorax, and finishes in the abdomen at the
stomach. The oesophagus is between 18 cm and 25 cm in length
and comprises skeletal muscle proximally, smooth muscle distally,
and a mixture in its central portion (Gatzoulis 2009). Boluses
of swallowed food are moved along this muscular tube by co-
ordinated waves of contractility, called peristalsis. Food or other
material can become ‘impacted’ in the oesophagus, resulting in
partial or total oesophageal obstruction. Many of these impactions
resolve spontaneously and therefore never present to healthcare
professionals (Liu 2012). The remainder may present acutely to
hospital emergency departments, with subsequent referral on to
ear, nose, and throat (ENT) surgeons or gastroenterologists for
further management.
Non-organic oesophageal foreign bodies, or organic food boluses
that have hard or sharp components (e.g. bone), pose a significant
risk of perforating the oesophageal wall (Barabino 2015; Mezzetto
2016; Park 2016). As such, they are managed diHerently as they
require immediate removal via rigid or flexible oesophagoscopy.
So# food boluses impacted in the oesophagus are not considered
to pose this same immediate risk and so may be subjected to
‘conservative’ strategies to encourage disimpaction, aiming to
avoid definitive endoscopic management. These so# food bolus
impactions were the focus of this review.
Any delay in disimpaction may expose the patient to potential
harm. Being unable to swallow causes distress and discomfort
and can rapidly lead to dehydration, as secretions are not
resorbed and normal enteral nutrition is prevented. Additionally,
the patient is at risk of aspirating these substances into the
tracheobronchial system, placing them at risk of pneumonia (Loh
2000). Finally, the bolus itself may also cause local trauma to
the adjacent oesophageal mucosa. This local pressure eHect may
cause inflammation, progressing to ischaemia, perforation, and
mediastinitis (Liu 2012). This carries a mortality approaching
100% if not treated promptly (Bladergroen 1986). As such, timely
disimpaction of these so# food boluses may be needed to prevent
serious sequelae.
Description of the intervention
An endoscopic procedure known as oesophagoscopy is considered
definitive management for persistent cases of impaction. The
lumen of the oesophagus is visualised, and the bolus is either
advanced into the stomach or retrieved through the mouth. This
may be performed with either a flexible or rigid endoscope, both
of which are associated with potentially serious complications
(Ferrari 2018; Wennervaldt 2012). The American Society for
Gastrointestinal Endoscopy recommends definitive management
of the oesophageal food bolus within 24 hours wherever
possible, to prevent complications from delayed disimpaction
(Ikenberry 2011; Loh 2000; Park 2004). Consequently, a number
of ‘conservative’ treatments and strategies are employed in an
attempt to avoid the need for endoscopic intervention within this
early period. This may involve a simple period of observation,
otherwise known as ‘watchful waiting’. Further to this, there are a
number of more active treatments that are commonly used. These
may be delivered parenterally, having their eHects on the tissues
of the oesophagus via the blood, or enterally, having a direct eHect
within the lumen of the oesophagus.
How the intervention might work
Watchful waiting
Observation, or watchful waiting, aims to allow more time for the
bolus to pass spontaneously. The muscle fibres surrounding the
bolus may be in spasm, and so a period of observation will allow
time for them to relax spontaneously and the bolus to pass into
the stomach through normal processes. Watchful waiting aims to
avoid the need for any form of intervention, whether endoscopic,
enteral, or parenteral, thereby avoiding any associated side eHects
or complications. However, there may be increased risks from this
delaying strategy, including immediate or late perforation if the
bolus remains impacted for too long (Loh 2000; Park 2004).
Parenteral treatments
Parenteral treatments may be administered subcutaneously,
intramuscularly, or intravenously. They are proposed to relax
the musculature of the oesophageal wall, thereby allowing the
impacted bolus to pass into the stomach. Depending on the level
of impaction within the oesophagus, these medications may target
smooth muscle or skeletal muscle. Commonly used medications
are highlighted below.
Benzodiazepines increase the eHects of gamma amino butyric acid
(GABA) at the GABA-A receptor, reducing the excitability of neurons.
Amongst other eHects, this can relax the skeletal muscle in the
proximal oesophagus. Benzodiazepines must be used cautiously
due to their potentially serious side eHect of central respiratory
depression (GriHin 2013).
Hyoscine butylbromide is an anticholinergic agent, which inhibits
parasympathetic actions on smooth muscle, resulting in relaxation
and dilatation. It may be given subcutaneously, intramuscularly,
or intravenously and is most commonly administered four times
daily (Tytgat 2007). There are no serious side eHects commonly
encountered with hyoscine butylbromide.
Glucagon is a single-chain polypeptide hormone that works to
raise serum glucose level and also relax smooth muscle in the
lower oesophageal sphincter and distal oesophagus. It may be
given subcutaneously, intramuscularly, or intravenously (Colon
1999). Side eHects include hyperglycaemia, and caution should be
exercised with use in diabetic patients.
Calcium channel blockers inhibit the entry of calcium ions into
smooth muscle cells, reducing their ability to contract and
so allowing dilatation (Katz 1986). They are used primarily in
cardiovascular disease, and so common potentially serious side
eHects include arrhythmias and hypotension. Calcium channel
blockers must be used with caution alongside other cardiovascular
drugs.
Enteral treatments
Enteral treatments work within the oesophageal lumen, directly on
the bolus itself. The patient may take them orally or they may be
administered through the nose with the help of a suitable conduit.
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Gas-forming or eHervescent agents, such as carbonated drinks,
may be drunk by the patient. The proposed mechanism of
action is to create increased pressure between the obstruction
and cricopharyngeal sphincter above, propelling the food bolus
inferiorly towards the stomach (David 2019).
Pineapple juice contains bromelain, which is a proteolytic enzyme
that aims to so#en and dissolve the food bolus (Thomas 2004).
Papain is derived from papaya fruit and has a similar proteolytic
mechanism of action. The practice of enzymatic disimpaction has
largely ceased because of the non-selective nature of the digestive
agents, aHecting not only the foreign body but also the oesophageal
wall, which may increase the risk of subsequent perforation (Morse
2016). Once so#ened, the impacted bolus may loosen, and normal
peristaltic actions may resume.
Non-endoscopic instrumentation of the bolus may also be
attempted, o#en through the nasal route to avoid stimulating a
gag reflex in the patient. A nasogastric (NG) tube may be passed
to interact with the bolus, without visualisation. The NG tube
may also be used to deliver liquids, such as eHervescent or
proteolytic agents, or gas, such as room air, proximal surface of the
bolus (Goldman 1994; Marano 2016). Blind instrumentation of an
obstructed oesophagus may pose a perforation risk, particularly
once it has been traumatised by an impacted food bolus.
Why it is important to do this review
Timely management of oesophageal food bolus impaction is
essential to prevent life-threatening complications, as outlined
previously. Prevailing clinical consensus suggests that non-
endoscopic treatments and strategies should be used initially to
help minimise the exposure to risk from endoscopic intervention.
However, there is no robust evidence as to which methods should
be employed, and for how long, before undergoing endoscopy.
Endoscopic interventions have the potential to bring about faster
resolution of the impaction, but the procedure carries potential
risks and complications. Safe and eHective treatments that help to
avoid endoscopic intervention would therefore be justified.
O B J E C T I V E S
To evaluate the eHicacy of non-endoscopic conservative
treatments in the management of so# food boluses impacted
within the oesophagus.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered randomised controlled trials that compared
conservative (non-endoscopic) treatments for impacted
oesophageal food boluses against other conservative (non-
endoscopic) treatments, placebo, or watchful waiting.
Types of participants
Inclusion criteria
• People of any age.
• History of acute so# food bolus ingestion.
• History suggestive of oesophageal impaction. This may manifest
as complete aphagia, suggesting a proximal blockage, or with
delayed regurgitation, which is more suggestive of a distal
oesophageal impaction.
• Reporting the incidence of disimpaction (confirmed
radiologically or clinically by return to oral diet) without the
need for endoscopic intervention, i.e. food bolus disimpaction
without the need for oesophagoscopy.
Exclusion criteria
• History of sharp- or solid-object ingestion, whether food
derived, such as animal bone, or ‘foreign’, such as dentures or
coins.
Types of interventions
We considered the following:
• all non-endoscopic treatments, as outlined above. These are
broadly divided into enteral treatments, parenteral treatments,
and watchful waiting;
• combinations of treatments, providing the allocated
management did not include endoscopy;
• all doses and dosing regimens;
• all relevant parenteral routes: subcutaneous, intramuscular, and
intravenous;
• all comparisons of the above treatments, including comparisons
with placebo.
Types of outcome measures
Primary outcomes
• Incidence of disimpaction, without the need for endoscopic
intervention, at any point prior to endoscopic intervention.
• Serious adverse events (including aspiration, perforation, and
death).
Secondary outcomes
• Adverse events (including side eHects and complications from
enteral and parenteral treatments and any sequelae during or as
a result of watchful waiting).
• Time to disimpaction, without the need for endoscopic
intervention.
• Patient satisfaction scores for diHerent treatment strategies.
• Length of hospital stay.
• Re-presentation with so# food bolus impaction within follow-up
period of the study.
Search methods for identification of studies
We conducted systematic searches of the published and
unpublished literature to identify randomised controlled trials
relevant to our review question. There were no restrictions
related to year of publication, publication status, or language
of publication, and we would have arranged translations if
appropriate. If further data were required to report the primary
outcomes, we would have sought clarification from the study
authors directly.
Electronic searches
We searched the following electronic databases to identify relevant
studies. We last conducted the searches on 18 August 2019.
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• Cochrane Central Register of Controlled Trials (CENTRAL)
(searched via Ovid; up to Issue 7, 2019) (Appendix 2).
• MEDLINE (searched via Ovid; 1946 to 18 August 2019) (Appendix
3).
• Embase (searched via Ovid; 1974 to 18 August 2019) (Appendix
4).
• CINAHL (Cumulative Index to Nursing and Allied Health
Literature) (searched via EBSCO; 1982 to 18 August 2019).
Searching other resources
We searched the reference lists of the articles retrieved, including
those of review articles. We attempted to contact authors of
relevant studies to ask them to identify any other published and
unpublished studies. We searched for errata or retractions of
eligible studies at www.ncbi.nlm.nih.gov/pubmed on 21 August
2019.
Data collection and analysis
Selection of studies
Two review authors (JH and NS) independently screened the titles
and abstracts of studies identified by the above search strategy. We
identified and excluded duplicates, and then coded unique articles
as either 'retrieve' (eligible or potentially eligible/unclear) or 'do
not retrieve' if clearly irrelevant. For articles coded as 'retrieve',
we obtained the full-text publication. Two review authors (JH and
NS) then independently assessed the text to identify studies for
inclusion. We excluded ineligible studies, recording the reasons
for exclusion in the Characteristics of excluded studies tables. Any
disagreements were resolved through discussion or in consultation
with a third review author (JS). Had we identified multiple reports
of the same study, we would have collated these, so that each study,
rather than each report, formed the unit of interest in the review.
The selection process is recorded in a PRISMA flow diagram (Figure
1).
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Figure 1.   PRISMA flow diagram of study selection process.
 
Data extraction and management
We used a standard data collection form for study characteristics
and outcome data that was pre-piloted and adapted as required.
Two review authors (JH and NS) independently extracted study
characteristics. We attempted to extract the following study
characteristics.
• Methods: study design, total duration study and run-in, number
of study centres and location, study setting, withdrawals, date
of study.
• Participants: N, mean age, age range, gender, severity of
condition, diagnostic criteria, baseline lung function, smoking
history, inclusion criteria, exclusion criteria.
• Interventions: intervention, comparison, concomitant
medications, excluded medications.
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• Outcomes: primary and secondary outcomes specified and
collected, and time points reported.
• Notes: funding for study, notable conflicts of interest of study
authors.
Two review authors (JH and NS) independently extracted outcome
data from the included studies (for details see Characteristics of
included studies). No outcome data were reported in an unusable
way. Any disagreements would have been resolved by consensus
or by involving a third review author (JS); this was not required as
there were no disagreements. One review author (JH) entered the
data from the data collection form into the Review Manager 5 file
(Review Manager 2014). A second review author (NS) verified this
for accuracy.
Assessment of risk of bias in included studies
Two review authors (JH and NS) independently assessed risk of
bias using the criteria outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). There were no
disagreements between review authors requiring arbitration by a
third review author. We assessed bias for the following domains.
• Random sequence generation.
• Allocation concealment.
• Blinding of participants and personnel.
• Blinding of outcome assessment.
• Incomplete outcome data.
• Selective outcome reporting.
• Other bias.
We graded each potential source of bias as either high, low, or
unclear and have provided quotes from the study report, together
with a justification for our judgement, in the 'Risk of bias' table.
Had information on risk of bias related to unpublished data or
correspondence with a trial author, we would have noted this in
the 'Risk of bias' table. When considering treatment eHects, we
assessed the risk of bias for the studies that contributed to that
outcome.
Assessment of bias in conducting the systematic review
We conducted the review in accordance with the published
protocol, reporting any deviations from it in the DiHerences
between protocol and review section.
Measures of treatment e;ect
We analysed dichotomous data as risk ratios. We would have
reported continuous data as mean diHerence or standardised mean
diHerence. We would have summarised time-to-event outcomes
using hazard ratios. We would have undertaken meta-analysis if
this were meaningful, that is if the treatments, participants, and
the underlying clinical question were similar enough for pooling to
make sense.
We did not encounter any reporting of medians and interquartile
ranges, which may have suggested skewed data, but would have
reported this and considered its implications.
Had we encountered multiple study arms in a single study, we
would have included only the relevant arms. If the same meta-
analysis needed two comparisons, we would have halved the
control group to avoid double counting.
Unit of analysis issues
We identified no non-standard parallel group random allocation
study designs. Had we identified cross-over studies, we would only
have considered the results from the first phase of the study, prior
to cross-over.
Dealing with missing data
We attempted to contact study investigators to clarify key study
characteristics and to obtain missing outcome data. Where
appropriate, we would have followed intention-to-treat principles.
Assessment of heterogeneity
We would have used the I2 statistic to measure heterogeneity
amongst the studies in each analysis (Higgins 2003). In the case
of substantial heterogeneity, we would have performed subgroup
analysis.
Assessment of reporting biases
Had we identified more than 10 studies for any individual
parameter, we would have produced a funnel plot to explore
potential publication bias. Sensitivity analysis for missing data was
not required.
Data synthesis
For quantitative analysis, we would have performed a meta-
analysis using Review Manager 5, Review Manager 2014, and a
random-eHects model (Deeks 2011).
'Summary of findings' table
We created a 'Summary of findings' table for the outcome
disimpaction of the so# food bolus prior to endoscopic
intervention.
We used the five GRADE considerations (study limitations,
consistency of eHect, imprecision, indirectness, and publication
bias) to assess the certainty of the body of evidence for this
outcome. Two review authors performed the GRADE assessment
(JH and NS), reaching a score by consensus and not requiring
arbitration by a third review author (JS).
We used the methods and recommendations described in Section
8.5 and Chapter 12 of the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011), employing GRADEpro
so#ware (GRADEpro 2015). We justified decisions to downgrade or
upgrade the certainty of the evidence in footnotes.
Subgroup analysis and investigation of heterogeneity
Had it been applicable, we would have performed subgroup
analysis of the type of conservative treatment, grouped by
substance type (irrespective of dose, regimen, or route) or watchful
waiting, with the aim of determining if any single enteral or
parenteral treatment outperformed another, including watchful
waiting. We would have used only the primary outcome measures.
Sensitivity analysis
Had it been required, we would have performed a sensitivity
analysis including only studies at low risk of bias for all domains
outlined in the Assessment of risk of bias in included studies
section.
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Reaching conclusions
We based conclusions on the findings from this review. We planned
to outline implications for both practice and research.
Summary of findings and assessment of the certainty of the
evidence
R E S U L T S
Description of studies
See Characteristics of included studies, Characteristics of excluded
studies, and Characteristics of studies awaiting classification for
further details.
Results of the search
We identified a total of 987 records through the electronic searches,
and one further record through the peer review process. We
excluded 98 duplicate records, leaving 890 unique records. We
excluded 809 clearly irrelevant records a#er title and abstract
assessment, retrieving the full texts of the remaining 81 records
for further assessment. We excluded 79 records and included one
randomised controlled trial that met the inclusion criteria. There
were no ongoing studies and one study awaiting classification, a#er
the paper was provided by a reviewer but verification of the data
was outstanding. The process of study selection is outlined in Figure
1.
Included studies
Tibbling 1995 is a randomised, placebo-controlled, double-
blinded, parallel-group trial including 43 participants, co-ordinated
from University Hospital, Linköping, Sweden. Three other Swedish
hospitals participated (University Hospital Uppsala and the central
hospitals of Jönköping and Norrköping), though the recruitment
rates at individual sites are not described. Participants were
randomised to receive either intravenous diazepam and glucagon
or identically appearing placebos. The primary outcome was
disimpaction of the foreign body. It was not stated how the
disimpaction was assessed, though radiological confirmation was
required for inclusion in the study. The eHects of the drugs were
followed for one hour before the initial outcomes were recorded.
Disimpactions occurring a#er one hour were also recorded, though
no standardised time point for this assessment was declared. There
was no indication of any a priori power calculation, but the authors
report that their intention was to recruit 40 participants. The study
was conducted over a two-year period and published in 1995 in the
journal Dysphagia (Springer-Verlag New York Inc).
Excluded studies
We identified one other randomised trial evaluating oesophageal
impaction (Mehta 2001), which we excluded as it looked only
at coin impactions. Reasons for exclusion of the majority of the
other studies that passed initial screening were retrospective/
prospective observational cohort studies, or limited case reports,
and not experimental trials with randomisation. For further details
see Characteristics of excluded studies.
Risk of bias in included studies
We assessed the risk of bias in the included study, Tibbling 1995,
using Cochrane's 'Risk of bias' tool as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Allocation
Tibbling 1995 does not specify the randomisation ratio, but it
is assumed to be 1:1. Randomisation was carried out centrally
in advance by a pharmacologist who retained the code until
recruitment had completed.
Blinding
Both active substances and placebos in Tibbling 1995 were clear,
colourless liquids distributed in identical glass ampoules from a
central pharmacy. Investigators and participants were thus blinded
as to the nature of the substances administered. There is no
indication that the concealment was broken at any point during the
trial for any participants.
Incomplete outcome data
Results are presented for 43 participants in Tibbling 1995. There is
no indication that any participants were recruited and randomised
but failed to complete the study. There was slight imbalance in
the recruited groups, with 24 receiving active substances and 19
receiving placebos.
Selective reporting
Tibbling 1995 appears to have presented outcomes for all
43 randomised participants. There was no declared intention
to perform subgroup analysis, and no subgroup analysis was
reported.
Other potential sources of bias
No baseline characteristics were presented for comparison
of the active substances and placebo group in the Tibbling
1995 publication. Confirmation that the groups, although
randomly allocated, were equivalent, would have been reassuring.
DiHerences in comorbidities, such as oesophageal strictures and
hiatus hernias, could have influenced the likelihood of a food bolus
clearing spontaneously.
Data on the time until endoscopy was performed for the
comparable groups were not provided. A delay could have allowed
more time for the bolus to clear spontaneously, thereby influencing
the success rates seen between the two groups if significantly
diHerent.
E;ects of interventions
See: Summary of findings 1 Diazepam and glucagon compared
to placebo for the management of impacted food bolus in the
oesophagus
See Summary of findings 1 for the main comparison.
Primary outcome measures
Disimpaction
The only data available were from the Tibbling 1995 publication of
43 participants. The rates of disimpaction for the active substance
and placebo groups were 37.5% (n = 9/24) and 31.6% (n = 6/19),
respectively (risk ratio 1.19, 95% confidence interval 0.51 to 2.75,
P = 0.69). It was not stated how disimpaction was measured,
radiologically or clinically. The eHects of the drugs were assessed
a#er one hour of the treatments being administered. If the food
bolus was still impacted, then the participant was prepared for
Conservative management of oesophageal so food bolus impaction (Review)
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oesophagoscopy under general anaesthetic. Within this initial hour,
four participants disimpacted across both groups. An additional
11 participants were said to have subsequently disimpacted and
so did not undergo endoscopy. The trial methodology did not
standardise the time at which the endoscopy was intended to
be performed. As such, we are not able to comment further on
the timeframe for these later disimpactions as no relevant data
were presented. We attempted to contact the study authors for
clarification on this point but did not received a response.
For the 15 participants who did not undergo oesophagoscopy, the
criteria for confirmation of disimpaction was not reported. In 26
of the 28 participants undergoing oesophagoscopy, an impacted
foreign body was extracted. It is not reported if the two remaining
participants had the bolus identified at the time of the procedure. It
is therefore possible that the two participants had a bolus present
at the time of the procedure that was then advanced into the
stomach, rather than being extracted via the mouth, or if there
was in fact no bolus present, implying that it had passed prior
to endoscopy, and the procedure could have been considered
unnecessary. With only 43 participants randomised in the trial,
these two cases could have significantly influenced the success rate
if they were both in the same treatment group.
Serious adverse events
No incidence of aspiration, perforation, or death was reported
as resulting from either the conservative management or the
endoscopic intervention (Tibbling 1995). Of note, it is not reported
whether the oesophagoscopy was performed with flexible or rigid
instruments.
Secondary outcome measures
Tibbling 1995 reported adverse events in 3 of the 24 participants
receiving active substances: 2 experienced a burning sensation at
the injection site, and 1 experienced hiccups. It was not reported
which agent caused which side eHect(s). Only 5 minutes were
allocated between the two drugs being administered, and so
attributing cause and eHect may have been impossible regardless.
Tibbling 1995 did not report the time for the impaction to
clear. The only available data were that 3 of the 24 participants
receiving active substances and 1 of the 19 participants receiving
placebos were reported to have disimpacted within one hour of
administration.
Patient satisfaction scores, length of stay, and re-presentation to
hospital were not reported.
D I S C U S S I O N
Summary of main results
So# food bolus impaction in the oesophagus is a frequently
encountered condition in emergency departments around the
world. A variety of non-procedural interventions are used to
manage the condition and are reported in the literature. Despite
this, there is a paucity of randomised trials on the topic, with only a
single study addressing the issue identified in this review (Tibbling
1995). Based on this study, there is uncertainty as to the eHects of
active substances on the rate of disimpaction of oesophageal so#
food boluses, when compared with placebo. There were insuHicient
data to comment on serious adverse events of any treatment
regimen considered in this review.
Overall completeness and applicability of evidence
The single identified trial assessed two intravenous medications
commonly used in the management of impacted oesophageal so#
food boluses, namely diazepam and glucagon. Both of these drugs
were administered to each participant randomised to the active
intervention group. As such, we could not assess the eHicacy of
either substance individually.
We identified no eligible studies addressing other parenteral
treatments. Similarly, we identified no eligible studies investigating
enteral treatments. Consequently, the completeness of evidence
addressing the treatments within the scope of this review is low.
The evidence identified here is applicable to adult patients, without
a history of oesophageal stricture, presenting to emergency
departments with an impaction history of less than two days.
However, the generalisability to an international population is
limited due to the contribution from only a single country, and
the small sample size means we have low confidence that this is
representative of even that population.
Quality of the evidence
The overall certainty of the evidence contributing to the main
outcome measure of disimpaction was low. The eHect size was not
significant, and the 95% confidence interval was wide, reflecting
the low precision of the findings in the single contributing study. We
identified no evidence for other outcome measures.
We did not identify any incomplete or unreported trials in the
review process, and so we feel that the risk of reporting bias and
publication bias for this topic is low.
Potential biases in the review process
The protocol was published prior to the start of the formal review
process. We feel that the search strategy was robust enough to
have identified all potentially contributory evidence. At least two
review authors were involved in the screening and identification
of relevant studies and the extraction and analysis of data. All
four review authors were involved in writing and approving the
manuscript through consensus. As such, we feel the opportunity to
introduce bias into the review process has been limited.
Agreements and disagreements with other studies or
reviews
There are no other systematic reviews and meta-analyses in the
literature that address this topic and consider only randomised
controlled trials. There are numerous reviews and articles reporting
the findings of observational studies, but none considering only
experimental studies that are directly comparable.
It is not possible to comment on concordance of individual studies
within the literature as only a single randomised trial was identified.
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A U T H O R S '   C O N C L U S I O N S
Implications for practice
There is currently inadequate data to recommend the use of any
conservative treatments in the management of oesophageal so#
food bolus impaction. The overall certainty of the evidence is
low, with only a single, small randomised trial contributing to this
assessment.
There are potentially serious side eHects and complications
from the treatments currently used to manage so# food bolus
impaction, as well as potentially serious consequences from
delaying disimpaction with a watchful waiting strategy. This review
has identified insuHicient evidence to adequately comment on the
adverse eHects of any proposed management strategy. Caution
should be exercised when using any of the treatments considered
in this review, including intentional delay of definitive endoscopic
management.
Implications for research
Significantly more experimental studies are needed before this
review question can be adequately addressed. All current
management strategies risk exposure of patients to potential harm,
whether that be from the treatments themselves, or from any
delay in impacted bolus being cleared. The single randomised
controlled trial identified by this review has too few participants
to adequately comment on the eHectiveness of the interventions
(diazepam and glucagon) or the eHectiveness of watchful waiting or
placebo. Future studies should consider randomising participants
at the time of presentation to either a definitive endoscopic
procedure, or a conservative management strategy including
observation, enteral and parenteral treatments. This will allow
adequate assessment of both the eHicacy of the treatments and of
any adverse events resulting from delay in treatment or definitive
endoscopic management itself.
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Study characteristics
Methods Double-blind, parallel-group, randomised, placebo-controlled trial
Participants Adults with foreign-body impaction in the oesophagus presenting to 4 Swedish ear, nose, and throat
(ENT) departments
Interventions Diazepam and glucagon
Outcomes Disimpaction
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "Randomization was made in five series of 10 by a pharmacologist at
the Linköping University Hospital who kept the code until all 40 patients had
been treated and evaluated."
Comment: co-ordinated centrally
Allocation concealment
(selection bias)
Low risk Quote: "Randomization was made in five series of 10 by a pharmacologist at
the Linköping University Hospital who kept the code until all 40 patients had
been treated and evaluated."
Comment: allocation was unknown until after consent and randomisation
Blinding of participants
and personnel (perfor-
mance bias)
All outcomes
Low risk Quote: "the placebo preparations were delivered in glass ampoules of identi-
cal appearance."
Comment: identical, placebo-controlled ampoules. No indication that con-
cealment was broken during treatment or observation period.
Blinding of outcome as-
sessment (detection bias)
All outcomes
Low risk Quote: "the placebo preparations were delivered in glass ampoules of identi-
cal appearance."
Comment: identical, placebo-controlled ampoules. No indication that con-
cealment was broken during treatment or observation period.
Incomplete outcome data
(attrition bias)
All outcomes
Unclear risk Quote: "The foreign body disimpacted in 38% (9/24) of those given active sub-
stances and in 32% (6/19) of those given placebo (not significant)."
Comment: outcomes recorded for all 43 participants declared as entering
study. Assumed complete follow-up and no attrition.
Selective reporting (re-
porting bias)
Low risk Comment: no subgroups to consider. Outcomes reported for all 43 partici-
pants. There was no a priori registration of the protocol to ensure that all in-
tended outcomes were reported.
Other bias Low risk No baseline characteristics presented. No breakdown of presentation/out-
come by site.
Tibbling 1995 
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Study Reason for exclusion
Al-Haddad 2006 Cohort study or case report
Anderson 2007 Review
Arora 2009 Review
Basavaraj 2005 Study protocol
Bekkerman 2016 Review
Bell 1988 Cohort study or case report
Bodkin 2016 Cohort study or case report
Borges 2014 Study protocol
Brady 1991 Review
Castell 1990 Study protocol
Chavez 2012 Cohort study or case report
Cheng 2017 Cohort study or case report
Cronan 1980 Cohort study or case report
Damghani 2011 Cohort study or case report
David 2017 Cohort study or case report
Debongnie 1981 Cohort study or case report
Dias 2017 Cohort study or case report
Elhamady 2017 Cohort study or case report
Fan 2017 Sharp/hard foreign body
Fass 2004 Review
Ferrari 2018 Review
Ghumman 2017 Cohort study or case report
Glauser 1979 Cohort study or case report
Goldman 1994 Cohort study or case report
Haas 2014 Cohort study or case report
Hall 1988 Cohort study or case report
Haridy 2017 Cohort study or case report
Hassan 2015 Cohort study or case report
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Study Reason for exclusion
Huang 2015 Cohort study or case report
Ibrahim 2019 Cohort study or case report
Jeen 2001 Sharp/hard foreign body
Kim 2016 Cohort study or case report
Kingsbery 2017 Review
Krzeski 1995 Cohort study or case report
Langoya 2016 Cohort study or case report
Lee 2005 Review
Leopard 2011 Review
Lorrains 2015 Review
Louie 2005 Cohort study or case report
Maglinte 1995 Review
Maini 2001 Cohort study or case report
Mazzadi 1998 Cohort study or case report
Mehta 2001 Sharp/hard foreign body
Monnier 2005 Editorial
Moons 2003 Cohort study or case report
Moores 1996 Cohort study or case report
Morse 2016 Cohort study or case report
Mosca 2001 Cohort study or case report
Nugent 2013 Review
Odelowo 1990 Cohort study or case report
Ooi 2017 Cohort study or case report
Ooi 2017a Cohort study or case report
Ooi 2018 Cohort study or case report
Ooi 2018a Cohort study or case report
Pan 2016 Cohort study or case report
Patoulias 2016 Sharp/hard foreign body
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Study Reason for exclusion
Peksa 2019 Review
Price 2007 Review
Robbins 1994 Cohort study or case report
Rodriguez-Sanchez 2013 Cohort study or case report
Ruan 2019 Cohort study or case report
Smith-Sivertsen 1985 Cohort study or case report
Sodeman 2004 Cohort study or case report
Thomas 2005 Cohort study or case report
Tihan 2011 Sharp/hard foreign body
Tilakaratne 2012 Review
Tokar 2007 Cohort study or case report
Van Der Sluis 2012 Cohort study or case report
Waltzman 2006 Sharp/hard foreign body
Weant 2012 Review
Willenbring 2018 Cohort study or case report
Woo 2015 Sharp/hard foreign body
Wu 2011 Cohort study or case report
Yan 2014 Cohort study or case report
Yuan 2019 Sharp/hard foreign body
Zamary 2017 Sharp/hard foreign body
Zimmers 1988 Cohort study or case report
 
Characteristics of studies awaiting classification [ordered by study ID]
 
Methods Single-blinded randomised controlled trial
Participants 42
Interventions Buscopan 20 mg (Boehringer Ingelheim, Bracknell, UK) versus placebo (same volume of normal
saline: 1 mL)
Basavaraj 2016 
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Outcomes Disimpaction assessed by clinical staH with liquid challenge
Notes Paper provided by reviewer but verification of data outstanding.
Basavaraj 2016  (Continued)
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Diazepam and glucagon compared to placebo for the management of impacted food bolus in the
oesophagus
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1.1 Disimpaction 1 43 Risk Ratio (M-H, Random, 95% CI) 1.19 [0.51, 2.75]
 
 
Analysis 1.1.   Comparison 1: Diazepam and glucagon compared to placebo for the
management of impacted food bolus in the oesophagus, Outcome 1: Disimpaction
Study or Subgroup
Tibbling 1995
Total (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
Experimental
Events
9
9
Total
24
24
Control
Events
6
6
Total
19
19
Weight
100.0%
100.0%
Risk Ratio
M-H, Random, 95% CI
1.19 [0.51 , 2.75]
1.19 [0.51 , 2.75]
Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Diazepam and glucagon Placebo
 
 
A P P E N D I C E S
Appendix 1. Glossary of terms
Aphagia – the loss of the ability to swallow
Arrhythmia – irregular heartbeat
Aspirating – the drawing of a foreign object (such as food) into the airway
Hyperglycaemia – an excess of glucose (a type of sugar) in the bloodstream
Hypotension – low blood pressure
Intramuscularly – administered through a muscle
Intravenously – administered through a vein (through the bloodstream)
Ischaemia – an inadequate blood supply
Lumen – the space inside a tubular structure within the body
Mediastinitis – inflammation of the tissues of the mid-chest
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Mortality – death rate
Pharynx – the cavity behind the nose and mouth
Serum – clear fluid separated from clotted blood
Regurgitation – the action of bringing up food into the mouth a#er it has been swallowed
Appendix 2. CENTRAL search strategy
1. exp Esophageal Stenosis/ and (exp Foreign Bodies/ or exp Food/)
2. (Steakhouse syndrome or steakhouse spasm*).mp.
3. ((esophag* or oesophag*) and (food* or meat foreign bod*) and (bolus or mass)).tw,kw.
4. ((esophag* or oesophag*) and (food* or meat or foreign bod*) and (impact* or aphagia or block* or regurgit*)).tw,kw.
5. ((esophag* or oesophag*) and (food* or meat or foreign bod*) and (obstruct* or stenosis or stenoses or strict* or narrow* or Constriction
or stuck*)).tw,kw.
6. or/1-5
Appendix 3. MEDLINE search strategy
1. exp Esophageal Stenosis/ and (exp Foreign Bodies/ or exp Food/)
2. (Steakhouse syndrome or steakhouse spasm*).mp.
3. ((esophag* or oesophag*) and (food* or meat foreign bod*) and (bolus or mass)).tw,kw.
4. ((esophag* or oesophag*) and (food* or meat or foreign bod*) and (impact* or aphagia or block* or regurgit*)).tw,kw.
5. ((esophag* or oesophag*) and (food* or meat or foreign bod*) and (obstruct* or stenosis or stenoses or strict* or narrow* or Constriction
or stuck*)).tw,kw.
6. or/1-5
7. randomized controlled trial.pt.
8. controlled clinical trial.pt.
9. random*.ab.
10.placebo.ab.
11.trial.ab.
12.groups.ab.
13.drug therapy.fs.
14.or/7-13
15.exp animals/ not humans.sh.
16.14 not 15
17.6 and 16
Note:
For RCT filter we used the “Box 6.4.c: Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity-
maximizing version (2008 revision); Ovid format”. We made the following minor revision: we used “random*” instead of “randomized.ab”
or “randomly.ab.” to capture word variations such as “randomised, randomization, random".
Appendix 4. Embase search strategy
1. (exp esophagus obstruction/ or exp esophagus stenosis/) and (exp esophagus foreign body/ or exp food/)
2. (Steakhouse syndrome or steakhouse spasm*).mp.
3. ((esophag* or oesophag*) and (food* or meat foreign bod*) and (bolus or mass)).tw,kw.
4. ((esophag* or oesophag*) and (food* or meat or foreign bod*) and (impact* or aphagia or block* or regurgit*)).tw,kw.
5. ((esophag* or oesophag*) and (food* or meat or foreign bod*) and (obstruct* or stenosis or stenoses or strict* or narrow* or Constriction
or stuck*)).tw,kw.
6. or/1-5
7. random:.tw.
8. clinical trial:.mp.
9. placebo:.mp.
10.double-blind:.tw.
11.or/7-10
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12.exp animal/ not human.sh.
13.11 not 12
14.6 and 13
Note: Combined one term and two terms min diHerence of high sensitivity and high specificty RCT filter: https://hiru.mcmaster.ca/hiru/
hedges/All-EMBASE.htm
W H A T ' S   N E W
 
Date Event Description
20 September 2019 New search has been performed Submitted for editorial approval
3 May 2017 Amended Protocol revised
 
H I S T O R Y
Protocol first published: Issue 4, 2008
Review first published: Issue 5, 2020
C O N T R I B U T I O N S   O F   A U T H O R S
John Hardman: protocol development; study selection; locating and retrieving full-text articles; data extraction; GRADE assessment;
writing and approving the final version of the review.
Neil Sharma: protocol development; study selection; data extraction; GRADE assessment; writing and approving the final version of the
review.
Joel Smith: protocol development; writing and approving the final version of the review.
Paul Nankivell: protocol development; writing and approving the final version of the review.
D E C L A R A T I O N S   O F   I N T E R E S T
JH: none known.
NS: none known.
JS: none known.
PN: none known.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
We made a number of terminology changes between the protocol and the main review. We broadly classified 'management' into
three categories: endoscopic, non-endoscopic, and watchful waiting. Endoscopic treatment is considered the definitive treatment for
oesophageal so# food bolus impaction, against which the other management types were considered.
We rephrased pharmacological and non-pharmacological agents as parenteral and enteral treatments, respectively. This allowed us to
consider the previous category of ‘procedural instrumentation’, without visualisation of the bolus, as an enteral treatment.
The medications considered in this review were all oH patent, and no novel agents were identified during the review process. As such, we
did not contact any specific drug manufacturers about possible industry-funded studies.
We clarified that the primary outcome was disimpaction and the primary outcome measure could be radiological or clinical confirmation
(return to oral diet).
We specified that the primary outcome of disimpaction should be time limited until the point of endoscopic intervention.
We clarified that the primary outcome was a requirement for inclusion in the review.
We clarified how we would test for heterogeneity and which statistics we would use for the comparisons for each outcome.
Conservative management of oesophageal so food bolus impaction (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
23
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Conservative Treatment  [*methods];  Deglutition Disorders  [etiology]  [*therapy];  Diazepam  [*administration & dosage];  Food
 [*adverse eHects];  Gastrointestinal Agents  [*administration & dosage];  Glucagon  [*administration & dosage];  Multicenter Studies as
Topic;  Muscle Relaxants, Central  [*administration & dosage];  Placebos  [administration & dosage];  Randomized Controlled Trials as
Topic
MeSH check words
Humans
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